Business Daily from THE HINDU group of publications
Saturday, Feb 24, 2007
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Outlook
Wockhardt targets $1-b revenue by 2009

Our Bureau

Plans to invest Rs 400 crore in capacity expansion

Advertisement
Bharat Matrimony

Mumbai Feb. 23 Drug-maker Wockhardt Ltd has chalked out a strategy to clock consolidated revenues of $1 billion by 2009, the Wockhardt Chairman, Mr Habil Khorakiwala, told investors. Last August, the company had management guru, Mr C.K. Prahalad, over at Wockhardt for a couple of days to assist in charting the strategy.

Sales of about $300 million will come from inorganic growth, or the companies acquired by the company. At present about $86 million comes from acquired companies, he said. He reiterated the company's appetite for acquisitions, as the company was sitting on $250 million. In the domestic market, the look-out is for brands in specific therapeutic areas, while the international acquisition targets market access, he said.

Regulatory Environment

The company's growth in the international markets will be driven by Europe and the US, he said. With Europe having a regulatory environment in place for bio-similar products, the focus will be on insulin. Among other things, the company is also bullish on the pen delivery-mechanism for insulin that it has developed.

On the company's insulin injection that had to be withdrawn from the domestic market late last year, he said that Wockhardt had started manufacturing the product at Aurangabad and it will be in the market in about four weeks.

The company is also looking at investing Rs 400 crore in capacity expansion. The money could be invested in new capacities to meet international requirements, he said. It's Special Economic Zone at Aurangabad, where the company has committed about Rs 1,000 crore over five years, is not going to see significant investment this year he said.

More Stories on : Outlook | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Wockhardt Hospitals plans IPO


Madhucon board okays pref issue
RIL board to meet on pref warrants
Ranbaxy loses Flomax patent case
Bata India suspends 180 staff
Bombay Rayon acquires stake in UK co
Budweiser beer to be made in India
Jaiprakash Hydro ties up with PowerGrid
M&A tax benefits should be extended to entire service sector
Premji gets a feel of Suguna Poultry's biz model
Panel moots pruning of interest rates for Dabhol
`Hind Copper net to cross Rs 400 crore'
Wockhardt targets $1-b revenue by 2009
JCB India plans to roll out two more models
Lancor looks to expand in southern property market


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line